Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Bruton's Tyrosine Kinase Targeting in Multiple Myeloma.
Int J Mol Sci. 2021 May 27;22(11):5707. doi: 10.3390/ijms22115707.
Int J Mol Sci. 2021.
PMID: 34071917
Free PMC article.
Review.
Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma.
Al-Odat OS, Guirguis DA, Schmalbach NK, Yao G, Budak-Alpdogan T, Jonnalagadda SC, Pandey MK.
Al-Odat OS, et al.
Int J Mol Sci. 2022 Dec 30;24(1):644. doi: 10.3390/ijms24010644.
Int J Mol Sci. 2022.
PMID: 36614089
Free PMC article.
Review.
Item in Clipboard
Development of a novel Bruton's tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells.
Elbezanti WO, Al-Odat OS, Chitren R, Singh JK, Srivastava SK, Gowda K, Amin S, Robertson GP, Nemmara VV, Jonnalagadda SC, Budak-Alpdogan T, Pandey MK.
Elbezanti WO, et al. Among authors: al odat os.
Front Pharmacol. 2022 Sep 9;13:894535. doi: 10.3389/fphar.2022.894535. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36160379
Free PMC article.
Item in Clipboard
Cite
Cite